Position in NYXH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,425,449
-$1,111,041 QoQ
Shares Held
843,461
-2.9% QoQ
Ownership
0.828%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#5
of 45 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NYXH Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Vestal Point Capital, LP holds $481,978,449 across 8 Medical Devices names. NYXH ranks #8 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
1,400,000 | $127,036,000 | |
| 2 | ZBH |
Zimmer Biomet Holdings, Inc.
|
1,400,000 | $120,526,000 | |
| 3 | PODD |
Insulet Corp
|
670,000 | $102,007,500 | |
| 4 | GMED |
Globus Medical Inc
|
850,000 | $67,158,500 | |
| 5 | GEHC |
GE HealthCare Technologies Inc.
|
450,000 | $28,804,500 | |
| 6 | BBNX |
Beta Bionics, Inc.
|
1,600,000 | $25,072,000 | |
| 7 | AVR |
Anteris Technologies Global Corp.
|
1,010,000 | $9,948,500 | |
| 8 | NYXH |
Nyxoah SA
This page
|
843,461 | $1,425,449 |
All Filings in NYXH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,425,449 | 843,461 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,536,490 | 868,661 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,092,200 | 1,107,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,094,099 | 1,107,413 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,486,974 | 1,402,002 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,186,298 | 2,318,954 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $23,393,728 | 2,924,216 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||